Jennifer Doudna, a UC Berkeley biochemist who shared the 2020 Nobel Prize in Chemistry for the invention of CRISPR-Cas9 genome editing, has been awarded a National Medal of Technology and Innovation, the nation’s highest honor for technological achievement.
Jennifer Doudna，加州大学伯克利分校分子与细胞生物学和化学教授 Jennifer Doudna，加州大学伯克利分校的生物化学家，因发明CRISPR-Cas9基因组编辑而获得2020年诺贝尔化学奖，被授予国家技术与创新奖章，这是美国技术成就的最高荣誉。
President Joe Biden named Doudna and 10 other technology medalists in a White House announcement on Friday, Jan. 3.
1月3日星期五，美国总统拜登在白宫宣布提名杜德纳和其他10名技术奖牌获得者。
Doudna is a professor of molecular and cell biology and of chemistry, a Howard Hughes Medical Institute investigator, a faculty scientist at the Lawrence Berkeley National Laboratory (Berkeley Lab) and founder of the Innovative Genomics Institute. At Berkeley, she holds the Li Ka Shing Chancellor’s Chair in Biomedical and Health Science and is the executive director of the Li Ka Shing Center for Genomic Engineering.
杜德纳是分子和细胞生物学及化学教授，霍华德休斯医学研究所研究员，劳伦斯伯克利国家实验室（伯克利实验室）的教员科学家和创新基因组学研究所的创始人。在伯克利，她担任生物医学和健康科学的李嘉诚校长主席，也是李嘉诚基因组工程中心的执行董事。
The medal was established by Congress in 1980 and first awarded in 1985. It is administered by the U.S. Patent and Trademark Office, but is bestowed annually by the president of the United States. In last Friday’s announcement, Biden also named 14 recipients of the National Medal of Science and two organizational recipients of the National Medal of Technology and Innovation.
该奖章于1980年由国会设立，1985年首次颁发。它由美国专利商标局管理，但每年由美国总统授予。在上周五的公告中，拜登还提名了14名国家科学奖章获得者和两名国家技术与创新奖章的组织获得者。
“Those who earn these awards embody the promise of America by pushing the boundaries of what is possible,” read a White House announcement about this year’s medalists. “These trailblazers have harnessed the power of science and technology to tackle challenging problems and deliver innovative solutions for Americans and for communities around the world.”
“那些获得这些奖项的人通过突破可能的界限，体现了美国的承诺，”白宫在关于今年的奖牌获得者的声明中写道。“这些开拓者利用科学技术的力量来解决具有挑战性的问题，并为美国人和世界各地的社区提供创新的解决方案。”
Doudna is the fourth Berkeley faculty member to receive the National Medal of Technology and Innovation. At least 34 faculty members have received the National Medal of Science.
杜德纳是伯克利大学第四位获得国家技术与创新奖章的教员。至少有34名教师获得了国家科学奖章。
Doudna and her European colleague and Nobel co-winner, Emmanuelle Charpentier, based their gene-editing technology on CRISPR systems that were discovered in bacteria. The technology has been revolutionary, serving as the basis of many promising medical technologies, including tools to diagnose and treat disease, and has many applications for the development of improved crops, biofuels and bioproducts.
杜德纳和她的欧洲同事、诺贝尔奖共同获得者艾曼纽尔·查彭蒂耶（Emmanuelle Charpentier）基于在细菌中发现的CRISPR系统开发了他们的基因编辑技术。这项技术是革命性的，是许多有前途的医疗技术的基础，包括诊断和治疗疾病的工具，并在开发改良作物、生物燃料和生物产品方面有许多应用。
The Food and Drug Administration and regulators in the United Kingdom have already approved a gene therapy treatment that uses CRISPR-Cas9 to treat sickle cell disease. Doudna’s team, through the Innovative Genomics Institute, is collaborating with physicians at UCLA and UCSF’s Benioff Children’s Hospital in Oakland on research to discover even better CRISPR therapies for sickle cell disease.
美国食品和药物管理局和英国的监管机构已经批准了一种使用CRISPR-Cas9治疗镰状细胞病的基因疗法。通过创新基因组学研究所，杜德纳的团队正在与加州大学洛杉矶分校和加州大学旧金山分校贝尼奥夫儿童医院的医生合作，研究发现更好的CRISPR治疗镰状细胞病的方法。
